Eli Lilly Strikes $650M Deal with Juvena to Develop Muscle-Boosting Drugs

Eli Lilly; Juvena Therapeutics; muscle-boosting drugs; AI drug discovery; muscle health; biotech collaboration; stem cell secreted proteins; drug development; obesity management; $650 million deal

Inside ASCO 2025: Big Data Drops and a Towering Campaign – Key News Highlights

ASCO 2025; cancer research; big data; campaigns; clinical oncology; artificial intelligence; HER2; lung cancer; breast cancer; therapeutic vaccines

FDA Places Clinical Hold on Five Gilead HIV Studies Due to Safety Concerns

FDA; Gilead Sciences; HIV; clinical hold; GS-1720; GS-4182; clinical trials; safety signal; CD4+ T-cell; lymphocyte count; Biktarvy; lenacapavir

Insmed’s TPIP PAH Therapy Advances to Phase III Following Positive Phase 2b Results

Insmed; TPIP; treprostinil palmitil inhalation powder; pulmonary arterial hypertension; PAH; Phase 2b trial; Phase III trial; clinical trial results; FDA engagement